Lobeline clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How each study uses Lobeline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Lobeline
- 3
Studies by the year they started
3 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
National Institute on Drug Abuse (NIDA) (3) · Yaupon Therapeutics (1)
Studies
Open first, then newest update. How each study uses Lobeline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1Status unknownPhase 1National Institute on Drug Abuse (NIDA)NCT00100074Written as Lobeline
- Ph1 Lobeline Interaction Study - 1Status unknownPhase 1National Institute on Drug Abuse (NIDA)NCT00439504Written as Lobeline
- Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1Status unknownPhase 1National Institute on Drug Abuse (NIDA)NCT00519259Written as Lobeline
- Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult PatientsCompletedPhase 2Yaupon TherapeuticsNCT00664703Written as Lobeline sulfate
Codes
What other systems call Lobeline · ClinicalTrials.gg INT007745
- MeSH (NLM) D008120LobelineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) D0P25S3P81LOBELINEConfirmed FDA, NLM, Wikidata
- RxNorm 6464Confirmed FDA, Wikidata
- Wikidata Q421905lobelineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C93261LobelineConfirmed FDA, Wikidata
- DrugBank DB05137One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008120 | Lobeline | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | D0P25S3P81 | LOBELINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6464 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421905 | lobeline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C93261 | Lobeline | Confirmed FDA, Wikidata |
| DrugBank | DB05137 | — | One source Wikidata |
Also registered as lobeline sulfate (UNII 4CJ480V2HP).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.